Improved
6112 HealthChanged
3786 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
.jpg)
Sponsored By: The Reconnect Study
Low sexual desire is one of the most common types of female sexual dysfunction (FSD) and it is estimated that one in 10 women may have the signs at some point in their lives. Types of FSD such as hypoactive sexual desire disorder (HSDD) can negatively impact women suffering from it, as well as their partners.
HSDD can be very uncomfortable, and physically and emotionally difficult to deal with. Some of the HSDD symptoms include: lack of sexual thoughts; lack of desire that cannot be attributed to any other medical or psychological problem. The key criteria of the disorder are that it causes personal distress for women suffering from it. Further, HSDD is often not reported nor recognized, and can take a serious toll on a woman's intimate relationships and self-esteem.
HealthyWomen.org and Palatin Technologies, (makers of bremelanotide, an investigational therapy for HSDD), recently surveyed 906 premenopausal women. Of these women, 46 percent surveyed experienced low sexual desire at some point in their lives. Survey results also showed about six women out of 10 were distressed about their reduced desire for sex.
But even though low sexual desire is common, and significantly affects the lives of millions of women, there are currently no FDA-approved drugs for treatment in the United States.
Nearly 92 percent of women who may be suffering from HSDD said that they would be interested in such a treatment, according to HealthyWomen.org. In addition, 58 percent of the women who participated in the poll would be interested in a treatment that can be taken on demand, as needed, when they choose to have sexual activity.
If you suspect you may be experiencing HSDD, learn more about the Reconnect Study. The clinical research study is evaluating an investigational medication for premenopausal women with decreased sexual desire. It is taken “as needed” shortly before a sexual encounter. It takes effect within 45 minutes and lasts for several hours.
To learn more about HSDD and the Reconnect Study, visit www.reconnectstudy.com or call 1-844-409-0909.
Sources:
Shifren JL, Monz BU, Russo PA, et al. Obstet Gynecol. 2008;112(5):970-978.
"Causes of Low Sex Drive | HealthyWomen." Causes of Low Sex Drive | HealthyWomen. Web. 12 July 2015. http://www.healthywomen.org/content/article/whats-really-causing-your-low-sex-drive?context=healthcenter/60&context_title=60
Hook, Debra-Lynn B. "What Is Hypoactive Sexual Desire Disorder?" EverydayHealth.com. Web. 12 July 2015. http://www.everydayhealth.com/sexual-health/hypoactive-sexual-desire-disorder.aspx
"Palatin Launches Reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction." Palatin Launches Reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female. Web. 12 July 2015. http://www.prnewswire.com/news-releases/palatin-launches-reconnectstudycom-in-support-of-bremelanotide-phase-3-program-for-female-sexual-dysfunction-300038848.html
"The Reconnect Study | Decreased Sexual Desire." The Reconnect Study | Decreased Sexual Desire. Web. 12 July 2015. https://www.reconnectstudy.com
Palatin Technologies, Inc. Life Science advisor. Web. 13 July 2015. http://www.lifesciadvisors.com/clientinfo/palatin/Palatin__LSA_Initiation_Report_1-8-14__clientinfo.pdf
Reviewed July 13, 2015
by Michele Blacksberg RN
Edited by Jody Smith
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!